What amount sold does Fulmer Instruments, LLC report in Form D filings?

The latest linked filings report $1.6M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Fulmer Instruments, LLC's most recent SEC filing?

Fulmer Instruments, LLC's most recent Form D filing was on 2022-01-07.

How many investors does Fulmer Instruments, LLC have?

The most recent Form D filing lists 22 investor(s).

What type of securities does Fulmer Instruments, LLC offer?

Fulmer Instruments, LLC's SEC Form D filings indicate debt offerings.

Fulmer Instruments, LLC

CIK: 0001687526·Biotechnology·MOUNTAIN BROOK, AL·Limited Liability Company

Reported Sold

$1,565,000

Total Filings

Identified Offerings

Last Filed

Jan 7, 2022

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jan 7, 2022Form D — New notice

Reported sold: $1,115,000 · Target: $1,115,000

Rule 506(b)·22 investors

Oct 14, 2016Form D — New notice

Reported sold: $450,000 · Target: $500,000

Rule 506(b)·15 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$1,565,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Benjamin Fulmer

Related Person

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Jan 7, 2022	New	$1,115,000	$1,115,000	22
Oct 14, 2016	New	$500,000	$450,000	15

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Khaya Biosciences, Inc.

Biotechnology

Offering target: $850,000

Filed Aug 13, 2026